Immunotherapy Flashcards
too little therapy
rejection
too much therapy
opportunistic infection
therapy stages
induction maintenance rejection
standard regimen
TAC + MMF or EC-MPS + Prednisone
secondary acquired immunodeficiencies
increase typical and opportunistic infections and cancers
what class needs TDM
CNI
Prograf
Tacrolimus IR BID DAW
Asatgraf XL
Tacolimus ER
Envarsus
Tacrolimus ER
70% of IR daily dose
Neoral
modified cyclosporine BID
Gengraf
modified CYA
Neoral and Gengraf are bioevquivalents and are interchangeable
true
Prograf is interchangeable with other TAC generics
false
Prograf and Astagraf are equivalent and interchangeable
false
Astagraf to Prograf compairson
1 mg ER : 1 mg IR
Sandimmune
non modified CYA
qd and not interchangeable
CYA AEs
hyperlipidemia nephrotoxicity tremor, HA HTN hyperglycemia gingival hyperplasia hirsutism d/v
TAC AEs
N/D nephrotoxicity tremor, HA Insomnia Hyperglycemia Hyperlipidemia HTN
DDI that inhibit CYP3A4
-azole antifungals antivirals (-VIR) CCB - diltiazem and verapamil gastric acid suppressors grapefruit juice
how would dosing change if there was a DDI inhibiting CYP3A4?
higher troughs resulting in lower dosing
how would dosing change if there was a DDI inducing CYP3A4
lower troughs resulting in higher dosing
DDI that induce CYP3A4
rifampin
caspofungin, terbinafine
phenytoin, phenobarbital, oxcarbazepine
st johns wart
Mycophenolate Mofetil
CellCept
MFF is a pro drug delayed release
False, it is a prog drug regular release